GlobalData

As per GlobalData report, pharma sector reports 112 deals worth $4.2 billion, with key contributions from Organon, Genentech, and…

The poll reveals that 90 per cent of the respondents consider the microbiome to be very important for health maintenance

mRNA technology could transform H5N1 vaccine landscape, enhancing future pandemic preparedness says GlobalData

With the growth in AD, investment opportunities seem to be exciting, and pharmaceutical companies could invest in the R&D of…

Mergers and acquisitions in the healthcare sector experience a significant decline, while venture capital investments also see a…

CGRP antagonists drive growth, but access and reimbursement barriers remain challenges

There is a huge opportunity for developers and manufacturers to advance novel prophylactic and treatment options, says GlobalData

COPD diagnosed prevalent cases in 7MM set to increase, with significant age and regional variations, according to GlobalData

Real-world data show rVSV-ZEBOV vaccine is 84 per cent effective against Ebola, supporting its use in future outbreaks

The approval could present a major challenge to Ocaliva (obeticholic acid), which was until recently the sole approved drug for…